Evidence map›Paper›PMID 21609843›Full record

ArticleChemistry & biology2011

Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells.

Sun H Peck, Irwin Chen, David R Liu

Open access · greenAbstract read
In one paragraph

Article in Chemistry & biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Inteins as Drug Targets and Therapeutic Tools.Frontiers in molecular biosciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Proximity Induced Splicing Utilizing Caged Split Inteins.Journal of the American Chemical Society · 2019
    Article
  15. Off-Pathway-Sensitive Protein-Splicing Screening Based on a Toxin/Antitoxin System.Chembiochem : a European journal of chemical biology · 2019
    Article
  16. Article
  17. Drug Inducible CRISPR/Cas Systems.Computational and structural biotechnology journal · 2019
    Review
  18. An Adaptable Platform for Directed Evolution in Human Cells.Journal of the American Chemical Society · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sun H PeckDepartment of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.
Irwin Chen
David R Liu
Howard Hughes Medical Institute · US

Funding

Expanding the Scope of Protein EvolutionR01GM065400 · NIGMS · HARVARD UNIVERSITY · PI LIU, DAVID R · 2002 to 2010
$2.5M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM065400
6 · The paper itself

Abstract

Laboratory-created small-molecule-dependent inteins enable protein structure and function to be controlled posttranslationally in living cells. Previously we evolved inteins that splice efficiently in Saccharomyces cerevisiae only in the presence of the cell-permeable small molecule 4-hydroxytamoxifen (4-HT). In mammalian cells, however, these inteins exhibited lower splicing efficiencies and slower splicing in the presence of 4-HT, as well as higher background splicing in the absence of 4-HT. Here we further evolved ligand-dependent inteins in yeast at 30°C and 37°C. The resulting second-generation evolved inteins exhibit substantially improved splicing yields and kinetics. The improvements carried over to mammalian cells, in which the newly evolved inteins spliced with substantially greater (∼2- to 8-fold) efficiency while maintaining low background splicing levels. These second-generation inteins augment the promise of ligand-dependent protein splicing for probing protein function in mammalian cells.

Indexed as

Directed Molecular EvolutionProtein SplicingCell LineHumansInteinsKineticsMutationProtein Structure, TertiaryRecombinant Fusion ProteinsSaccharomyces cerevisiaeTamoxifenTemperatureafimoxifeneRecombinant Fusion ProteinsTamoxifen

Identifiers

PMID21609843
PMCPMC3124510
OpenAlexW2101056890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.